These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33172220)

  • 1. New Insights on Molecular Mechanism of Hepatitis B Virus Covalently Closed Circular DNA Formation.
    Marchetti AL; Guo H
    Cells; 2020 Nov; 9(11):. PubMed ID: 33172220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.
    Cai D; Yan R; Xu JZ; Zhang H; Shen S; Mitra B; Marchetti A; Kim ES; Guo H
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
    J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.
    Guo H; Jiang D; Zhou T; Cuconati A; Block TM; Guo JT
    J Virol; 2007 Nov; 81(22):12472-84. PubMed ID: 17804499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
    Tang L; Sheraz M; McGrane M; Chang J; Guo JT
    PLoS Pathog; 2019 Apr; 15(4):e1007742. PubMed ID: 31026293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Hepatitis B Virus cccDNA Formation.
    Wei L; Ploss A
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
    Hofmann S; Plank V; Groitl P; Skvorc N; Hofmann K; Luther J; Ko C; Zimmerman P; Bruss V; Stadler D; Carpentier A; Rezk S; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2023 Jun; 11(3):e0044623. PubMed ID: 37199632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.
    Köck J; Rösler C; Zhang JJ; Blum HE; Nassal M; Thoma C
    PLoS Pathog; 2010 Sep; 6(9):e1001082. PubMed ID: 20824087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses.
    Königer C; Wingert I; Marsmann M; Rösler C; Beck J; Nassal M
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4244-53. PubMed ID: 25201958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Virus Capsid: The Core in Productive Entry and Covalently Closed Circular DNA Formation.
    Mendenhall MA; Hong X; Hu J
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
    Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
    PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Hepatitis B Virus cccDNA and Minichromosome Formation and HBV Gene Transcription.
    Gómez-Moreno A; Ploss A
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.
    Chen Y; Yao Y; Zhao K; Liu C; Yuan Y; Sun H; Huang D; Zheng Y; Zhou Y; Chen J; Wang Y; Wu C; Zhang B; Guan Y; Li F; Pei R; Chen X
    J Virol; 2022 Jul; 96(13):e0058522. PubMed ID: 35862693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA.
    Tang L; An P; Zhao Q; Winkler CA; Chang J; Guo JT
    J Virol; 2023 Jan; 97(1):e0126122. PubMed ID: 36519896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation.
    Luo J; Luckenbaugh L; Hu H; Yan Z; Gao L; Hu J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus cccDNA is formed through distinct repair processes of each strand.
    Wei L; Ploss A
    Nat Commun; 2021 Mar; 12(1):1591. PubMed ID: 33707452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance.
    Tu T; Zehnder B; Qu B; Ni Y; Main N; Allweiss L; Dandri M; Shackel N; George J; Urban S
    Antiviral Res; 2020 Sep; 181():104865. PubMed ID: 32726641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.
    Ko C; Su J; Festag J; Bester R; Kosinska AD; Protzer U
    Antiviral Res; 2021 Oct; 194():105140. PubMed ID: 34284057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.